• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2017 年世界卫生组织分类和第 8 版美国癌症联合委员会胰腺神经内分泌肿瘤分期系统有哪些新内容？

What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?

机构信息

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

出版信息

Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27.

DOI:10.3348/kjr.2018.0040
PMID:30627018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6315069/
Abstract

The diagnosis and management of pancreatic neuroendocrine neoplasms (NENs) have evolved significantly in recent years. There are several diagnostic and therapeutic challenges and controversies regarding the management of these lesions. In this review, we focus on the recent significant changes and controversial issues regarding the diagnosis and management of NENs and discuss the role of imaging in the multidisciplinary team approach.

摘要

近年来，胰腺神经内分泌肿瘤（NENs）的诊断和治疗有了显著的发展。在这些病变的管理方面，存在一些诊断和治疗方面的挑战和争议。在这篇综述中，我们重点讨论了 NENs 的诊断和治疗方面的最新重大变化和争议问题，并讨论了影像学在多学科团队方法中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/1a48ff022c00/kjr-20-5-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/2878e3cc6417/kjr-20-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/4309c43194c7/kjr-20-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/18223f644957/kjr-20-5-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/e23c6765af2d/kjr-20-5-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/822483e96cfc/kjr-20-5-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/1a48ff022c00/kjr-20-5-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/2878e3cc6417/kjr-20-5-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/4309c43194c7/kjr-20-5-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/18223f644957/kjr-20-5-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/e23c6765af2d/kjr-20-5-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/822483e96cfc/kjr-20-5-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fda/6315069/1a48ff022c00/kjr-20-5-g006.jpg

相似文献

1
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?2017 年世界卫生组织分类和第 8 版美国癌症联合委员会胰腺神经内分泌肿瘤分期系统有哪些新内容？
Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27.
2
Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的系统治疗排序与联合应用
J Clin Oncol. 2015 May 10;33(14):1534-8. doi: 10.1200/JCO.2014.59.0927. Epub 2015 Apr 13.
3
Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.胰腺神经内分泌肿瘤（pNEN）的诊断性影像学检查：肿瘤检测、分期、预后及对治疗的反应
Acta Radiol. 2016 Mar;57(3):260-70. doi: 10.1177/0284185115579932. Epub 2015 Apr 8.
4
Diagnostic protocol for pancreatic neuroendocrine tumors (PNETs).胰腺神经内分泌肿瘤（PNETs）的诊断方案
Rev Esp Enferm Dig. 2012 Feb;104(1):29-32. doi: 10.4321/s1130-01082012000100006.
5
Pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤
Minerva Gastroenterol Dietol. 2012 Dec;58(4):401-26.
6
The Role of PET/CT in the Imaging of Pancreatic Neoplasms.PET/CT在胰腺肿瘤成像中的作用。
Semin Ultrasound CT MR. 2019 Dec;40(6):500-508. doi: 10.1053/j.sult.2019.04.006. Epub 2019 Apr 25.
7
Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms.舒尼替尼使 NET-G3 胰腺神经内分泌肿瘤缩小。
J Cancer Res Clin Oncol. 2018 Jun;144(6):1155-1163. doi: 10.1007/s00432-018-2636-2. Epub 2018 Mar 30.
8
Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.肝胆胰：冯·希佩尔-林道病中的胰腺混合性浆液性神经内分泌肿瘤。
J Gastroenterol Hepatol. 2018 Nov;33(11):1821. doi: 10.1111/jgh.14274. Epub 2018 Jun 10.
9
Principles of diagnosis and management of neuroendocrine tumours.神经内分泌肿瘤的诊断与管理原则
CMAJ. 2017 Mar 13;189(10):E398-E404. doi: 10.1503/cmaj.160771.
10
Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.68Ga-DOTATOC与18F-FDG联合正电子发射断层扫描/计算机断层扫描在胰腺神经内分泌肿瘤诊断检查中的作用：对手术决策管理的启示
Pancreas. 2017 Jan;46(1):42-47. doi: 10.1097/MPA.0000000000000745.

引用本文的文献

1
Radiological Variability in Pancreatic Neuroendocrine Neoplasms: A 10-Year Single-Center Study on Atypical Presentations and Diagnostic Challenges.胰腺神经内分泌肿瘤的放射学变异性：一项关于非典型表现和诊断挑战的10年单中心研究
Biomedicines. 2025 Feb 17;13(2):496. doi: 10.3390/biomedicines13020496.
2
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study.2级消化神经内分泌肿瘤的临床和生物学异质性：10% Ki-67指数临界值的预后意义及对治疗策略的影响。一项纵向研究。
J Endocrinol Invest. 2025 Feb 19. doi: 10.1007/s40618-025-02552-1.
3

本文引用的文献

1
Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.评估美国癌症联合委员会第 8 版分期系统用于胰腺神经内分泌肿瘤患者：监测、流行病学和最终结果分析。
Cancer Med. 2018 Mar;7(3):626-634. doi: 10.1002/cam4.1336. Epub 2018 Jan 29.
2
Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.分化良好的胰腺神经内分泌肿瘤（PanNETs）和低分化胰腺神经内分泌癌（PanNECs）：概念、问题和高级别（G3）病例的实用诊断方法。
Histopathology. 2018 Jan;72(1):168-177. doi: 10.1111/his.13408.
3
Deciphering pancreatic neuroendocrine tumors: Unveiling through circulating small extracellular vesicles.
解读胰腺神经内分泌肿瘤：通过循环小细胞外囊泡揭示奥秘。
Heliyon. 2024 Apr 1;10(7):e29079. doi: 10.1016/j.heliyon.2024.e29079. eCollection 2024 Apr 15.
4
Primary Oral Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN): A Rare Case Report and Review of the Literature.原发性口腔混合性神经内分泌-非神经内分泌肿瘤（MiNEN）：一例罕见病例报告及文献复习。
Head Neck Pathol. 2024 Feb 23;18(1):13. doi: 10.1007/s12105-024-01613-w.
5
Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report.舒尼替尼治疗坏死性游走性红斑患者取得良好疗效：一例报告
Open Life Sci. 2023 Nov 27;18(1):20220672. doi: 10.1515/biol-2022-0672. eCollection 2023.
6
Occurrence of Immune Thrombocytopenic Purpura Following Enucleation of a Neuroendocrine Tumor of the Head of the Pancreas.胰腺头部神经内分泌肿瘤摘除术后发生免疫性血小板减少性紫癜
Cureus. 2023 Oct 16;15(10):e47109. doi: 10.7759/cureus.47109. eCollection 2023 Oct.
7
Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.消化系统神经内分泌肿瘤的 WHO 分类与基于位置和功能的分类之间的关系。
Neuroendocrinology. 2024;114(2):120-133. doi: 10.1159/000534035. Epub 2023 Sep 8.
8
Circulating hsa-miR-5096 predicts F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.循环中的hsa-miR-5096可预测F-FDG PET/CT阳性并调节生长抑素受体2的表达：一种用于胰腺神经内分泌肿瘤的基于miR的新型检测方法。
Front Oncol. 2023 May 23;13:1136331. doi: 10.3389/fonc.2023.1136331. eCollection 2023.
9
Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤门静脉期 CT 肿瘤与实质增强比值的预后价值。
Eur Radiol. 2023 Apr;33(4):2713-2724. doi: 10.1007/s00330-022-09235-y. Epub 2022 Nov 15.
10
Pancreatic Neuroendocrine Tumor (PNET) Presenting as a Pseudocyst: A Case Report.表现为假性囊肿的胰腺神经内分泌肿瘤（PNET）：一例报告
Cureus. 2022 Sep 26;14(9):e29617. doi: 10.7759/cureus.29617. eCollection 2022 Sep.
A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.比较伴有和不伴有肿瘤内纤维化的胰腺神经内分泌肿瘤患者在动态增强 CT 上的强化模式和生存情况。
Abdom Radiol (NY). 2017 Dec;42(12):2835-2842. doi: 10.1007/s00261-017-1212-6.
4
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
5
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.基于形态学的3级胰腺神经内分泌肿瘤的治疗反应和结果：高分化与低分化
Pancreas. 2017 Mar;46(3):296-301. doi: 10.1097/MPA.0000000000000735.
6
Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.基于美国癌症联合委员会和欧洲神经内分泌肿瘤学会系统的胰腺神经内分泌肿瘤改良分期分类。
J Clin Oncol. 2017 Jan 20;35(3):274-280. doi: 10.1200/JCO.2016.67.8193. Epub 2016 Sep 30.
7
Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.胰腺神经内分泌肿瘤：增强计算机断层扫描特征与肿瘤病理分级之间的相关性
Eur J Radiol. 2015 Aug;84(8):1436-1443. doi: 10.1016/j.ejrad.2015.05.005. Epub 2015 May 14.
8
Recent developments in imaging of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤成像的最新进展。
Ann Gastroenterol. 2015 Apr-Jun;28(2):193-202.
9
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别（世界卫生组织G3级）胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性，包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
10
Solid pancreatic tumors with unilocular cyst-like appearance on CT: differentiation from unilocular cystic tumors using CT.CT 表现为单房囊性类似物的实性胰腺肿瘤：与单房囊性肿瘤的 CT 鉴别诊断。
Korean J Radiol. 2014 Nov-Dec;15(6):704-11. doi: 10.3348/kjr.2014.15.6.704. Epub 2014 Nov 7.